Process Development Forum is an online resource for information on innovations and technologies supporting the bioprocessing development spectrum. Subscribe to the Bioprocess Development Forum eNewsletter.
August 8, 2024
Address the complexity of protein characterization
Since the FDA approved the first monoclonal based therapy in 1985, mAbs have had significant…
September 21, 2023
High-concentration monoclonal antibody drugs: manufacturing challenges
The growth in the formulation of drugs suitable for delivery by subcutaneous (Sub-C) injection...
February 23, 2017
Impact of Manufacturing-Scale Freeze-Thaw Conditions on a mAb Solution
The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions...
March 30, 2016
A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications
The Chinese hamster ovary (CHO) cell lines used for the production of recombinant therapeutic proteins...
November 22, 2013
Evolution of the Monoclonal Antibody Purification Platform
BioPharm InternationalBy: Anurag S. Rathore, Ranga Godavarti, Vijesh Kumar, Nihal Tugcu for BioPharm International The…